It is estimated in the U.S. that there will be about 11,050 new cases of childhood cancer being diagnosed in 2020 alone. The types of cancer that are most common among children differ from those that are most common for adults. Children tend to most commonly develop leukemia, brain and spinal cord tumors, neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, retinoblastoma and bone cancer.
The type of treatment children receive is dependent on their specific type of cancer and how much it has advanced. Common treatments are surgery, chemotherapy, radiation therapy, immunotherapy and stem cell transplants. Before any treatment can be made available to patients, however, they have to be studied and researched through clinical trials in order to be approved for safety and efficiency. Clinical trials are a good option for children because they study new devices, treatments and procedures that have yet to be implemented in standard care, which grants children with cancer first access to these and also works towards improving research on childhood cancer. Since children can sometimes require different sizes or doses of certain treatments from those used on adults, clinical trials for children’s cancers are important to consider, since the majority of standard care treatments are studied on adults.